After withdrawing an improved offer to buy ISTA Pharmaceuticals, Valeant Pharmaceuticals has entered into a definitive agreement to acquire Eyetech in order to expand its presence in the ophthalmology market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: PharmaDeals Ltd